Neurodegeneration

Neurodegeneration

A digital illustration of a human brain with blue veins and a glowing light at the top, set against a black background.
“Neurotech is not just about the brain,” says Synchron CTO Riki Banerjee, explaining how their tech can help with paralysis, brain diseases, and beyond.
Two colorful cells with purple nuclei, green cell edges, and radiating filament structures against a black background.
The findings suggest that biochemical and physical effects of exercise could help heal nerves.
Overlay of hands with abstract purple and black lines in the background.
“The field is endless, but my life is limited, as are all of ours. But you do what you can with your time,” says CSO Mart Saarma.
Illustration of a hand cutting red tape with scissors over a government building labeled "National of Health.
There is one obstacle that reliably blocks innovative ideas: how we fund science.
Close-up of a hand holding a blue object, with a digitally altered, grainy effect and a circular line overlay on the image. The background features a mix of white, red, and pink hues.
GLP-1 agonists may be able to treat addiction, prevent Alzheimer’s, and more.
An illustration of a bacterium on a black background related to Parkinson's disease.
Growing evidence suggests a link between the debilitating neurological illness and the microbes that live in our intestines. The vagus nerve may be a pathway.
A man with sunglasses and a hat on against a purple background.
Decades of Alzheimer's research might have missed a cellular culprit hiding in plain sight.
a diagram of the human body and its structures.
"Domesticated viral genes" may not be domesticated as scientists thought.
Pathogenic, self-propagating proteins called prions found in the brains of people with Alzheimer's are also found in Down syndrome patients.
"Jumping genes" exist in various forms, including as remnants of ancient retroviruses, and make up about 45% of the human genome.
How could we fight Alzheimer's with the body's own immunity?
A recent study reveals how nerve insulation becomes impaired in the brains of Alzheimer's patients.
An independent researcher looks into why there's such strong opposition to her research.
Their neurons are very different from "normal" people.
For over three decades, toxic proteins were believed to cause Alzheimer’s disease. However, recent studies suggest it might be metabolic reprogramming.
adhd alzheimer's disease
Noradrenaline-targeting drugs, including blood pressure, depression, and ADHD meds, improve Alzheimer's disease symptoms.
The plant-like sea creatures contain a molecule that improves memory, learning, and even hair quality, according to a new study in mice.
protein diseased brain
Protein fibrils accumulate in the brain during neurodegeneration. Cryo-electron microscopy has now uncovered fibrils of an unexpected protein.
Older adults who napped at least once or for more than an hour a day had a 40% higher chance of developing Alzheimer’s than those who napped less.
post-stroke dementia
Researchers look to an FDA-approved drug ingredient that can "scoop-up" and store cholesterol and possibly stave off post-stroke dementia.
alzheimer's vaccine
The cause of Alzheimer's is still not fully understood, but we might be able to vaccinate against it anyway.